You are here

  • Home
  • Archive
  • Volume 45, Issue 11
  • The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of β-thalassaemia

Article Text

Article menu
Download PDFPDF
Letters to JMG
The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of β-thalassaemia
  1. C-C So1,
  2. Y-Q Song2,
  3. S T Tsang1,
  4. L-F Tang2,
  5. A Y Chan1,
  6. E S Ma3,
  7. L-C Chan1
  1. 1
    Department of Pathology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China
  2. 2
    Department of Biochemistry, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China
  3. 3
    Department of Pathology, Hong Kong Sanatorium and Hospital, Hong Kong SAR, China
  1. Dr C-C So, Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China; scc{at}pathology.hku.hk

Abstract

Background: Fetal haemoglobin (HbF) level modifies the clinical severity of HBB disorders. Intergenic variants of HBS1L-MYB on chromosome 6q23 have recently been shown to be a major quantitative trait locus (QTL) influencing HbF levels in normal Caucasian adults.

Methods: A unique and well-characterised cohort of 238 Chinese subjects with β-thalassaemia trait was used to conduct a single-nucleotide polymorphism (SNP) association study for HbF level.

Results: Within this locus, 29 trait-associated SNPs in a non-coding 56 kb segment were identified. They were divided into five linkage disequilibrium (LD) blocks in the Chinese participants.

Conclusions: The data independently validate for the first time the significance of the HBS1L-MYB intergenic region in regulating HbF expression in a separate ethnic group that has a high prevalence of β-thalassaemia. Functional studies to unravel the biological significance of this region in regulating HbF production is clearly indicated, which may lead to new strategies to modify the disease course of severe HBB disorders.

https://doi.org/10.1136/jmg.2008.060335

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests: None.

    • Funding: This study was supported by General Research Fund Grant HKU 775307M of the Research Grant Council, Hong Kong.

    • Accession numbers: The National Center for Biotechnology Information (NCBI) Entrez database accession numbers for the genes discussed in this paper are: HBS1-like (HBS1L): GeneID: 10767. V-myb myeloblastosis viral oncogene homolog (MYB): GeneID: 4602. Haemoglobin, beta (HBB): GeneID: 3043. Haemoglobin, gamma A (HBG1): GeneID: 3047. Haemoglobin, gamma G (HBG2): GeneID: 3048